Home Page
BEIJING--June 4, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Chinese pharmaceutical company Walvax Biotechnology Company Limited recently was approved to perform clinical trials for its recombinant coronavirus vaccine, according to Chinese National Medical Products Administration. To date, 640 million Chinese citizens have received a vaccine for COVID-19.
(All Fields Required)
Site-wide Scheduled Maintenance for September 27, 2025 from 12 P.M. to 6 P.M. CDT. Expect intermittent web site availability during this time period.
×Contact Us
For More Info!
